Related Posts
- Molecular Profiling of Circulating Tumor Cells in mRCC Over Time
KEY TAKEAWAYS A phase II multicenter adaptive immunotherapy OMNIVORE trial investigated the prognostic value of…
- PD-L1 Expression on Circulating Tumor Cells Predicts Prognosis in OMNIVORE Trial
KEY TAKEAWAYS The phase 3 OMNIVORE trial aimed to evaluate the efficacy of liquid biopsy…
- IL15 modification enables CAR T cells to act as a dual targeting agent against tumor cells and myeloid-derived suppressor cells in GBM
Introduction The immunosuppressive tumor microenvironment (TME) is a major barrier to the efficacy of chimeric…